Stay updated on Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding lapse notice and the v3.4.1 revision entry.
    Difference
    0.5%
    Check dated 2026-02-11T14:25:48.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding and NIH Clinical Center operating status was added to the site; link to opm.gov for updates. The site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:39:44.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added and updated administrative metadata on the study page: No FEAR Act Data, Last Update Submitted that Met QC Criteria, Last Update Posted, and Revision: v3.4.0. Removed the older labels Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.3%
    Check dated 2026-01-28T06:34:58.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Footer revision updated to v3.3.4 (replacing v3.3.3); no changes to study content, eligibility criteria, locations, or outcomes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:50:50.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The Study Record Dates section now shows 'Last Update Posted (Estimated)' in place of 'Last Update Posted'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-07T02:02:46.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Updates to the study timeline include a primary completion date of 2026-06-30 and a study completion date of 2026-06-30, with additional updates logged on 2025-12-28 and 2025-12-30.
    Difference
    0.3%
    Check dated 2025-12-31T00:18:47.000Z thumbnail image

Stay in the know with updates to Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page.